These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 6612628)

  • 21. Meltspun cellulose diacetate and polysulfone membranes have the same effect on complement activation and expression of leukocyte adhesion molecules and complement receptors.
    Dameche L; Brunet P; George F; André-Pinon S; Bernard D; Sampol J; Berland Y
    Nephrol Dial Transplant; 1995; 10 Suppl 10():33-8. PubMed ID: 8825430
    [No Abstract]   [Full Text] [Related]  

  • 22. Soluble tumor necrosis factor receptors are increased in hemodialysis patients.
    Ward RA; Gordon L
    ASAIO J; 1993; 39(3):M782-6. PubMed ID: 8268644
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of dialysis dose and membrane flux in maintenance hemodialysis.
    Locatelli F
    N Engl J Med; 2003 Apr; 348(15):1491-4; author reply 1491-4. PubMed ID: 12691051
    [No Abstract]   [Full Text] [Related]  

  • 24. Clinical evaluation of Altra-Flux 140 cellulose diacetate hollow-fiber dialyzer.
    Kes P; Ratković-Gusić I; Prsa M
    Acta Med Croatica; 1996; 50(1):45-8. PubMed ID: 8776116
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biocompatibility of a polycarbonate membrane. A preliminary report.
    De Broe ME; van Waeleghem JP; Heyrman R; De Backer W
    Blood Purif; 1986; 4(1-3):168-71. PubMed ID: 3015165
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of dialysis dose and membrane flux in maintenance hemodialysis.
    Friedman EA
    N Engl J Med; 2003 Apr; 348(15):1491-4; author reply 1491-4. PubMed ID: 12691049
    [No Abstract]   [Full Text] [Related]  

  • 27. Leucocyte occlusion of cuprophane membranes as a cause of reduced hemodialysis efficiency.
    Dodd NJ; Parsons V; Weston MJ
    Int J Artif Organs; 1982 Jul; 5(4):275-6. PubMed ID: 7118290
    [No Abstract]   [Full Text] [Related]  

  • 28. Clinical characterization of Dicea a new cellulose membrane for haemodialysis.
    Hoenich NA; Woffindin C; Cox PJ; Goldfinch M; Roberts SJ
    Clin Nephrol; 1997 Oct; 48(4):253-9. PubMed ID: 9352161
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Does the biocompatibility of the hemodialysis membrane influence the prognosis of acute renal insufficiency?].
    Tielemans C; Gastaldello K; Melot C; Kahn RJ; Vanherweghem JL
    Nephrologie; 1998; 19(2):89-91. PubMed ID: 9592779
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Microcapsule artificial kidney: including updated preparative procedures and properties.
    Chang TM
    Kidney Int Suppl; 1976 Dec; (7):S218-24. PubMed ID: 1070536
    [No Abstract]   [Full Text] [Related]  

  • 31. [Thermal energy balance during hemodialysis: the role of the filter membrane].
    Panzetta G; Bianco F; Galli G; Ianche M; Savoldi S; Vianello S; Vidi E; Cicinato P
    G Ital Nefrol; 2002; 19(4):425-31. PubMed ID: 12369045
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Hypersensitivity reactions related to acetate dialyzate and cellulose acetate membrane.
    Caravaca F; Pizarro JL; Arrobas M; Cubero JJ; Antona JM; Sanchez E
    Nephron; 1987; 45(2):158-9. PubMed ID: 3561625
    [No Abstract]   [Full Text] [Related]  

  • 33. [Clinical evaluation of new cellulose acetate membranes for hemodialysis. Preliminary results].
    Palla R; Carmassi F; Bionda A; Donadio C; Morelli E; Bianchi R; Mariani G
    Minerva Nefrol; 1979; 26(4):561-6. PubMed ID: 542226
    [No Abstract]   [Full Text] [Related]  

  • 34. [Blood purification for patients with chronic renal failure accompanied by severe liver disease].
    Inoue K; Yoshiba M
    Nihon Rinsho; 2004 Jun; 62 Suppl 6():66-9. PubMed ID: 15250270
    [No Abstract]   [Full Text] [Related]  

  • 35. [Adsorbents in extrarenal purification of the body].
    Gorbovitskiĭ EB; Levitskiĭ ER
    Vestn Akad Med Nauk SSSR; 1978; (1):79-87. PubMed ID: 343427
    [No Abstract]   [Full Text] [Related]  

  • 36. [Indications for hemodialysis in acute renal insufficiency].
    Kuzin MI; Sorokina MI; Troĭniakov NK; Dobrovol'skiĭ VI; Tsydenov MM
    Sov Med; 1976; (9):99-102. PubMed ID: 996623
    [No Abstract]   [Full Text] [Related]  

  • 37. Release of pyrogens during clinical hemodialysis.
    Weingast JA; VanDeKerkhove KM; Eiger SM; Kluger MJ; Port FK
    Trans Am Soc Artif Intern Organs; 1985; 31():359-62. PubMed ID: 3837472
    [No Abstract]   [Full Text] [Related]  

  • 38. Membrane selection for renal replacement therapy: a mountain or molehill?
    Farrell PC; Odell RA
    Contrib Nephrol; 1985; 44():97-111. PubMed ID: 3886286
    [No Abstract]   [Full Text] [Related]  

  • 39. The cardiopulmonary manifestations of blood-dialyzer (new and reused) interactions in an animal model.
    Lindsay RM; Walker JF
    Trans Am Soc Artif Intern Organs; 1984; 30():711-4. PubMed ID: 6533968
    [No Abstract]   [Full Text] [Related]  

  • 40. Milky fluid elicited by cellulose triacetate membrane dialyzer, hyperlipidemia, and elevated C-reactive protein.
    Watanabe S; Morita M; Hirabayashi N; Yoshida T
    Ren Fail; 2020 Nov; 42(1):302-303. PubMed ID: 32312120
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.